FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of the general formula (I) having a high antagonistic activity with respect to human S1P2, and can be used to prepare a drug for treatment of a disease mediated by S1P2, such as a disease caused by vasoconstriction, fibrosis and respiratory disease.
EFFECT: compound application efficiency increase.
14 cl, 2 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PHENYL DERIVATIVES | 2012 |
|
RU2619105C2 |
NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST | 2015 |
|
RU2669938C2 |
USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE | 2014 |
|
RU2663620C2 |
USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
NEW BICYCLIC COMPOUNDS AS DOUBLE INHIBITORS OF AUTOTAXIN (ATX)/CARBONIC ANHYDRASE (CA) | 2016 |
|
RU2725138C2 |
SOLID COMPOSITION WITH IMPROVED SOLUBILITY AND STABILITY AND METHOD OF OBTAINING IT | 2005 |
|
RU2375046C2 |
NEW COMPOUNDS | 2001 |
|
RU2261245C2 |
PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
PREVENTIVE OR THERAPEUTIC REMEDY FOR PHOTODERMATOSIS | 2021 |
|
RU2812785C1 |
4-AMINOPIPERIDINE DERIVATIVES, METHODS FOR THEIR PREPARING, COMPOUNDS, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2266282C2 |
Authors
Dates
2017-12-25—Published
2014-03-25—Filed